Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

Fountain Life adds APEX to premium longevity program

Fountain Life has launched APEX, a premium membership program that redefines preventive healthcare by integrating continuous monitoring with performance assessments. This initiative moves beyond the traditional annual checkup model, offering a more personalized and ongoing approach to health optimization. APEX combines advanced diagnostics, including full-body and brain MRIs, genome sequencing, and blood biomarker analysis, with new features such as Functional Movement & Mobility Range Assessment and VO₂ Max Testing. This shift emphasizes not only the identification of health issues but also actionable insights and ongoing lifestyle guidance.

The significance of APEX lies in its potential to enhance healthspan through a comprehensive understanding of both biological and functional health. The Functional Movement Assessment employs 3D motion capture technology to evaluate joint mobility and movement quality, addressing the often-overlooked aspects of aging that affect daily life, such as mobility and independence. Meanwhile, VO₂ Max Testing serves as a critical indicator of cardiovascular fitness and overall health, providing insights into an individual’s ability to sustain an active lifestyle. These additions position APEX as a forward-thinking model in preventive care, focusing on measurable outcomes rather than just diagnostic data.

The takeaway from Fountain Life’s APEX initiative is its potential to reshape the landscape of longevity-focused healthcare. By prioritizing continuous engagement and actionable health insights, APEX could influence research paradigms and therapeutic strategies in aging biology. This model not only addresses immediate health concerns but also empowers individuals to take charge of their longevity journey, aligning with the growing consumer demand for proactive health management. As the premium prevention market evolves, APEX exemplifies a shift from reactive to proactive care, emphasizing the importance of maintaining functional well-being in the pursuit of a longer, healthier life.

Source: longevity.technology